References
- Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2011. National vital statistics reports; Vol. 61 No. 5. Hyattsville (MD): National Center for Health Statistics; 2012
- Iacovidou N, Varsami M, Syggellou A. Neonatal outcome of preterm delivery. Ann NY Acad Sci 2010;1205:130–4
- Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515--25
- Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;3:CD004454, 1--141
- Barondiot C, Morel O, Vieux R, et al. Antenatal betamethasone during pregnancy with severe diabetes: is better worse than good? Arch Pediatr 2007;14:989–92
- Schumacher A, Sidor J, Bühling KJ. Continuous glucose monitoring using the glucose sensor CGMS in metabolically normal pregnant women during betamethasone therapy for fetal respiratory distress syndrome. Z Geburtshilfe Neonatol 2006;210:184–90
- Olefsky JM, Kruszynska YT. Insulin resistance. In: Shanahan J, Noujaim S, Holton B, eds. Ellenberg and Rifkin's diabetes mellitus. 6th ed. New York: McGraw-Hill Companies; 2003:367--400
- Pedersen J: Diabetes and pregnancy. Blood sugar of newborn infants. PhD Thesis. Copenhagen: Danish Science Press; 1952
- Németh I, Szeleczki T, Boda D. Hyperbilirubinemia and urinary D-glucaric acid excretion in premature infants following antepartum dexamethasone treatment. J Perinat Med 1981;9:35–9
- Sann L, Burnod J, Lasne Y, Bethenod M. Antenatal administration of bethamethasone: effects upon neonatal blood glucose in premature infants. Nouv Presse Med 1979;8:3147–8
- Rokicki W, Krasnodebski J. Antenatal glucocorticoid administration and neonatal glycemia. Dev Pharmacol Ther 1987;10:307–11
- Centers for Disease Control and Prevention. National Diabetes Fact Sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011
- Caughey AB, Cheng YW, Stotland NE, et al. Maternal and paternal race/ethnicity are both associated with gestational diabetes. Am J Obstet Gynecol 2010;202:616.e1–5
- Star J, Hogan J, Sosa ME, Carpenter MW. Glucocorticoid-associated maternal hyperglycemia: a randomized trial of insulin prophylaxis. J Matern Fetal Med 2000;9:273–7
- Iafusco D, Stoppoloni F, Salvia G, et al. Use of real time continuous glucose monitoring and intravenous insulin in type 1 diabetic mothers to prevent respiratory distress and hypoglycaemia in infants. BMC Pregnancy Childbirth 2008;8:23 . doi: 10.1186/1471-2393-8-23
- Dalziel SR, Walker NK, Parag V, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomized controlled trial. 2005;365:1856–62